YU47570B - Postupak za sintezu omeprazola - Google Patents

Postupak za sintezu omeprazola

Info

Publication number
YU47570B
YU47570B YU99291A YU99291A YU47570B YU 47570 B YU47570 B YU 47570B YU 99291 A YU99291 A YU 99291A YU 99291 A YU99291 A YU 99291A YU 47570 B YU47570 B YU 47570B
Authority
YU
Yugoslavia
Prior art keywords
synthesis
omeprazole
methoxy
omeprazol
procedure
Prior art date
Application number
YU99291A
Other languages
English (en)
Other versions
YU99291A (sh
Inventor
A.E. Brandstrom
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Priority to HR920770A priority Critical patent/HRP920770B1/xx
Publication of YU99291A publication Critical patent/YU99291A/sh
Publication of YU47570B publication Critical patent/YU47570B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)

Abstract

POSTUPAK ZA SINTEZU OMEPRAZOLA, naznačen time, što se izvode stupnjevi reagovanja 5-metoksi-2-((4-metoksi-3,5-dimetil-2-piridinil)metiltio)-1H-benzimidazola (jedinjenje I) m-hlorperoksibenzoevom kiselinom u rastvoru metilen hlorida, pri konstantnom pH od oko 8,0 do 8,6 ekstrahovanja reagujuće smeše vodenim NaOH, razdvajanja vodene faze od organske faze, i dodavanja alkil formijata u vodenu fazu, čime se ostvaruje kristalizacija omeprazola. Prijava sadrži još 8 zavisnih zahteva.
YU99291A 1990-06-07 1991-06-05 Postupak za sintezu omeprazola YU47570B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HR920770A HRP920770B1 (en) 1990-06-07 1992-10-01 Improved method for synthesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002043A SE9002043D0 (sv) 1990-06-07 1990-06-07 Improved method for synthesis

Publications (2)

Publication Number Publication Date
YU99291A YU99291A (sh) 1993-11-16
YU47570B true YU47570B (sh) 1995-10-03

Family

ID=20379708

Family Applications (1)

Application Number Title Priority Date Filing Date
YU99291A YU47570B (sh) 1990-06-07 1991-06-05 Postupak za sintezu omeprazola

Country Status (42)

Country Link
US (1) US5386032A (sh)
EP (1) EP0533752B1 (sh)
JP (1) JP2993122B2 (sh)
KR (1) KR0178045B1 (sh)
CN (1) CN1040536C (sh)
AP (1) AP216A (sh)
AT (1) ATE162790T1 (sh)
AU (1) AU640246B2 (sh)
BG (1) BG61265B1 (sh)
CA (1) CA2083605C (sh)
CZ (1) CZ279928B6 (sh)
DE (1) DE69128832T2 (sh)
DK (1) DK0533752T3 (sh)
DZ (1) DZ1504A1 (sh)
EG (1) EG19392A (sh)
ES (1) ES2113378T3 (sh)
FI (1) FI102967B (sh)
GR (1) GR3026642T3 (sh)
HK (1) HK1003831A1 (sh)
HR (1) HRP920770B1 (sh)
HU (1) HU214323B (sh)
IE (1) IE911845A1 (sh)
IL (1) IL98274A (sh)
IS (1) IS1752B (sh)
LT (1) LT3584B (sh)
LV (1) LV10271B (sh)
MA (1) MA22171A1 (sh)
NO (1) NO300541B1 (sh)
NZ (1) NZ238224A (sh)
PL (1) PL165433B1 (sh)
PT (1) PT97873B (sh)
RO (1) RO111366B1 (sh)
RU (1) RU2061693C1 (sh)
SA (1) SA91120027B1 (sh)
SE (1) SE9002043D0 (sh)
SG (1) SG48053A1 (sh)
SK (1) SK278505B6 (sh)
TN (1) TNSN91042A1 (sh)
UA (1) UA32524C2 (sh)
WO (1) WO1991018895A1 (sh)
YU (1) YU47570B (sh)
ZA (1) ZA913779B (sh)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521100C2 (sv) * 1995-12-15 2003-09-30 Astra Ab Förfarande för framställning av en bensimidazolförening
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
US6437139B1 (en) 1997-05-06 2002-08-20 Pdi-Research Laboratories, Inc. Synthesis of pharmaceutically useful pyridine derivatives
CA2204580A1 (en) * 1997-05-06 1998-11-06 Michel Zoghbi Synthesis of pharmaceutically useful pyridine derivatives
KR100463031B1 (ko) * 1997-05-26 2005-04-06 동아제약주식회사 5-메톡시-2-[3,5-디메틸-4-메톡시피리딜메틸)설피닐]-1h-벤즈이미다졸의신규제조방법
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704183D0 (sv) 1997-11-14 1997-11-14 Astra Ab New process
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SI20019A (sl) 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6191148B1 (en) 1998-08-11 2001-02-20 Merck & Co., Inc. Omerazole process and compositions thereof
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
DE19951960C2 (de) 1999-10-28 2002-06-27 Gruenenthal Gmbh Verfahren zur Herstellung als Ulkustherapeutika geeigneter Benzimidazol-Derivate
JP2004524303A (ja) 2001-02-02 2004-08-12 テバ ファーマシューティカル インダストリーズ リミティド 置換された２−（２−ピリジルメチル）スルフィニル−１ｈ−ベンゾイミダゾール類の製造方法
KR100783020B1 (ko) * 2001-03-23 2007-12-07 동아제약주식회사 2-메틸클로라이드 피리딘 유도체 및 이를 이용한 벤즈이미다졸 유도체의 제조 방법
NZ530168A (en) 2001-07-16 2004-08-27 Janssen Pharmaceutica Nv Improved process for preparing benzimidazole-type compounds
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
SE0203092D0 (en) 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005007115A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2579665C (en) 2004-09-13 2014-03-18 Takeda Pharmaceutical Company Limited Method and apparatus for producing oxidized compound
PL1802584T3 (pl) * 2004-10-11 2010-03-31 Ranbaxy Laboratories Ltd Sposób wytwarzania podstawionych sulfotlenków
KR100641534B1 (ko) 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법
EP1954669B1 (en) 2005-12-01 2015-07-08 Auspex Pharmaceuticals, Inc. Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
WO2007129328A2 (en) * 2006-05-09 2007-11-15 Cadila Healthcare Limited Process for preparing 2-[pyridinyl]sulfinyl-substituted benzimidazoles
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EA200900985A1 (ru) 2007-01-31 2009-12-30 Крка, Товарна Здравил, Д. Д., Ново Место Способ получения оптически чистого омепразола
HUE031070T2 (en) 2007-03-15 2017-06-28 Auspex Pharmaceuticals Inc Deuterated d9-venlafaxine
GB2471619B (en) * 2008-03-31 2012-10-31 Council Scient Ind Res Method for the simultaneous preparation of 3-acetoxy-17-acetamdo-16-formyl-androst-5,16-diene and 3-acetoxy-2'-chloro-5-androsteno[17,6-B]pyridine
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN102786513A (zh) * 2011-05-18 2012-11-21 中国医学科学院药物研究所 奥美拉唑晶e型物质及制备方法与在药品和保健品中应用
WO2013108068A1 (en) 2012-01-21 2013-07-25 Jubilant Life Sciences Limited Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers
BR112022005578A2 (pt) 2019-09-24 2022-09-20 Prolacta Bioscience Inc Composições e métodos para tratamento de doenças inflamatórias e imunes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148930B (sh) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4307102A (en) * 1981-02-19 1981-12-22 Sterling Drug Inc. Phenanthro[2,3-c]pyrazole
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8500996D0 (sv) * 1985-03-01 1985-03-01 Haessle Ab Method of treatment
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds

Also Published As

Publication number Publication date
NO924682D0 (no) 1992-12-04
NO924682L (no) 1992-12-04
PT97873A (pt) 1992-04-30
FI925529A0 (fi) 1992-12-04
NO300541B1 (no) 1997-06-16
IS1752B (is) 2000-07-21
BG61265B1 (en) 1997-04-30
JP2993122B2 (ja) 1999-12-20
SE9002043D0 (sv) 1990-06-07
EP0533752A1 (en) 1993-03-31
FI102967B1 (fi) 1999-03-31
RO111366B1 (ro) 1996-09-30
PL165433B1 (pl) 1994-12-30
KR0178045B1 (en) 1999-03-20
CN1040536C (zh) 1998-11-04
TNSN91042A1 (fr) 1992-10-25
HU214323B (hu) 1998-03-02
YU99291A (sh) 1993-11-16
DE69128832T2 (de) 1998-05-28
CS172691A3 (en) 1992-01-15
US5386032A (en) 1995-01-31
JPH05507699A (ja) 1993-11-04
SG48053A1 (en) 1998-04-17
EG19392A (en) 1995-06-29
DE69128832D1 (de) 1998-03-05
LV10271B (en) 1995-04-20
RU2061693C1 (ru) 1996-06-10
HU9203855D0 (en) 1993-03-29
GR3026642T3 (en) 1998-07-31
HRP920770A2 (en) 1995-12-31
FI925529A (fi) 1992-12-04
CA2083605C (en) 1998-12-08
LT3584B (en) 1995-12-27
IL98274A0 (en) 1992-06-21
IL98274A (en) 1995-03-30
AP9100274A0 (en) 1991-07-31
HK1003831A1 (en) 1998-11-06
CZ279928B6 (cs) 1995-08-16
AU8080791A (en) 1991-12-31
IS3711A7 (is) 1991-12-08
LV10271A (lv) 1994-10-20
NZ238224A (en) 1993-11-25
BG97146A (bg) 1993-12-24
AP216A (en) 1992-09-02
ES2113378T3 (es) 1998-05-01
PT97873B (pt) 1998-10-30
CN1058211A (zh) 1992-01-29
DK0533752T3 (da) 1998-06-02
UA32524C2 (uk) 2001-02-15
IE911845A1 (en) 1991-12-18
HRP920770B1 (en) 2000-06-30
HUT63408A (en) 1993-08-30
MA22171A1 (fr) 1991-12-31
WO1991018895A1 (en) 1991-12-12
SK278505B6 (en) 1997-08-06
CA2083605A1 (en) 1991-12-08
LTIP1711A (en) 1995-07-25
SA91120027B1 (ar) 2002-06-03
ATE162790T1 (de) 1998-02-15
FI102967B (fi) 1999-03-31
DZ1504A1 (fr) 2004-09-13
EP0533752B1 (en) 1998-01-28
ZA913779B (en) 1992-02-26
AU640246B2 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
YU47570B (sh) Postupak za sintezu omeprazola
RU92016535A (ru) Способ получения омепразола
BR9912883A (pt) Processo para a preparação de omeprazol, 5-metóxi-2- [ [4-metóxi-3, 5-dimetil-2-piridinil) -metil] -sulfinil] 1h-benzimidazol (omeprazol), composição, e, composição farmacêutica
BR0111230A (pt) Composto, e, uso e processo para a preparação do mesmo
EP1897877A3 (en) Process for producing crystal
RU98110659A (ru) Способ синтеза соединений бензимидазола
CO4750654A1 (es) Proceso para la sintesis de un compuesto omeprazol
NO323468B1 (no) Fremgangsmate for fremstilling av derivater av [[(substituert pyridyl)metyl]tio]benzimidazol, et mellomprodukt samt en fremgangsmate for oppnaelse av mellomproduktet
DE60314105D1 (de) Alkylammoniumsalze von omeprazol und esomeprazol
FI903936A0 (fi) Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl.
DK0763047T3 (da) Ny fremgangsmåde til fremstilling af nucleosider
DE3776590D1 (de) 2-pyridyl-penem-verbindungen.
HUP9903744A2 (hu) Eljárás omeprazol előállítására
KR840005132A (ko) 트리아졸 항균제의 제조방법
JO1707B1 (en) An improved method of construction
DK0555351T3 (da) Oxysulfonylcarbamater
TH26860EX (th) วิธีที่ได้ปรับปรุงให้ดีขึ้นสำหรับการสังเคราะห์
KR960703406A (ko) 치환된 아릴티오알킬티오피리딘(substituted arylthioalkylthiopyrdines)
KR830007687A (ko) 7-아실아미노-3-(티오-치환)메틸-3-세펨-4-카르복실산 1-옥시드 유도체류의 제조방법
ES8500938A1 (es) Un procedimiento para preparar 2-(2-((5-dimetilaminometil) furan-2-ilmetiltio)etilamino)-5-(6-metilpirid-3-ylmetil)pirimid-4-ona.
KR880001623A (ko) 질소 함유 헤테로 사이클릭 화합물의 제조 방법